07:25 AM EST, 02/19/2025 (MT Newswires) -- Charles River Laboratories International ( CRL ) reported Q4 non-GAAP earnings Wednesday of $2.66 per diluted share, up from $2.46 per share a year earlier.

Analysts polled by FactSet expected $2.53.

Revenue for the quarter ended Dec. 28 was $1 billion, compared with $1.01 billion a year earlier.

Analysts surveyed by FactSet expected $983.6 million.

The company expects full-year 2025 non-GAAP earnings of $9.10 to $9.60 per share. Analysts surveyed by FactSet expect $9.60 per share. The company expects a revenue decrease for 2025 of 7% to 4.5%. Analysts polled by FactSet expect $3.87 billion.